Ivan Rubio‐Gayosso

985 total citations
36 papers, 783 citations indexed

About

Ivan Rubio‐Gayosso is a scholar working on Endocrinology, Diabetes and Metabolism, Physiology and Molecular Biology. According to data from OpenAlex, Ivan Rubio‐Gayosso has authored 36 papers receiving a total of 783 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Endocrinology, Diabetes and Metabolism, 9 papers in Physiology and 8 papers in Molecular Biology. Recurrent topics in Ivan Rubio‐Gayosso's work include Nitric Oxide and Endothelin Effects (6 papers), Hormonal and reproductive studies (5 papers) and Estrogen and related hormone effects (5 papers). Ivan Rubio‐Gayosso is often cited by papers focused on Nitric Oxide and Endothelin Effects (6 papers), Hormonal and reproductive studies (5 papers) and Estrogen and related hormone effects (5 papers). Ivan Rubio‐Gayosso collaborates with scholars based in Mexico, United States and Chile. Ivan Rubio‐Gayosso's co-authors include Steven H. Platts, Brian R. Duling, Guillermo Ceballos, Israel Ramírez‐Sánchez, Francisco Villarreal, Eduardo Meaney, T Morato, Nayelli Nájera, José Alfredo Sierra-Ramírez and Horacio Osorio‐Alonso and has published in prestigious journals such as International Journal of Molecular Sciences, Biochemical Pharmacology and Life Sciences.

In The Last Decade

Ivan Rubio‐Gayosso

33 papers receiving 770 citations

Peers

Ivan Rubio‐Gayosso
Éva Szabó Hungary
Ivan Rubio‐Gayosso
Citations per year, relative to Ivan Rubio‐Gayosso Ivan Rubio‐Gayosso (= 1×) peers Éva Szabó

Countries citing papers authored by Ivan Rubio‐Gayosso

Since Specialization
Citations

This map shows the geographic impact of Ivan Rubio‐Gayosso's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ivan Rubio‐Gayosso with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ivan Rubio‐Gayosso more than expected).

Fields of papers citing papers by Ivan Rubio‐Gayosso

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ivan Rubio‐Gayosso. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ivan Rubio‐Gayosso. The network helps show where Ivan Rubio‐Gayosso may publish in the future.

Co-authorship network of co-authors of Ivan Rubio‐Gayosso

This figure shows the co-authorship network connecting the top 25 collaborators of Ivan Rubio‐Gayosso. A scholar is included among the top collaborators of Ivan Rubio‐Gayosso based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ivan Rubio‐Gayosso. Ivan Rubio‐Gayosso is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Carrillo‐Hidalgo, Isabel, et al.. (2025). Phytochemical compounds against mild cognitive impairment key proteins: An in-silico approach. Journal of Applied Pharmaceutical Science.
2.
Valle‐Mondragón, Leonardo del, Ivan Rubio‐Gayosso, Rogélio Hernández‐Pando, et al.. (2025). Fenofibrate as a Modulator of the Renin–Angiotensin System in Su/Hx-Induced Pulmonary Arterial Hypertension. International Journal of Molecular Sciences. 26(21). 10251–10251.
3.
Ramírez‐Sánchez, Israel, Ivan Rubio‐Gayosso, Carlos Palma‐Flores, et al.. (2024). Neurological Restorative Effects of (-)-Epicatechin in a Model of Gulf War Illness. Journal of Medicinal Food. 27(11). 1070–1079. 3 indexed citations
4.
Rubio‐Gayosso, Ivan, et al.. (2023). Ketorolac and (-)-Epicatechin change retinal GFAP and NRF2 expression on hyperglycemic CD1 mice. Journal of Neuroimmunology. 375. 578018–578018. 1 indexed citations
5.
Carbó, Roxana, Mabel Buelna‐Chontal, Horacio Osorio‐Alonso, et al.. (2021). Cold exposure aggravates pulmonary arterial hypertension through increased miR-146a-5p, miR-155-5p and cytokines TNF-α, IL-1β, and IL-6. Life Sciences. 287. 120091–120091. 31 indexed citations
6.
Osorio‐Alonso, Horacio, et al.. (2020). Nutraceuticals in the Treatment of Pulmonary Arterial Hypertension. International Journal of Molecular Sciences. 21(14). 4827–4827. 10 indexed citations
7.
Castillo, Carmen, Guillermo Ceballos, Nayelli Nájera, et al.. (2020). Arginase inhibition by (−)-Epicatechin reverses endothelial cell aging. European Journal of Pharmacology. 885. 173442–173442. 20 indexed citations
8.
Gómez‐Pérez, Lydia, et al.. (2019). Humor Improves Women’s but Impairs Men’s Iowa Gambling Task Performance. Frontiers in Psychology. 10. 2538–2538. 3 indexed citations
9.
Arellano-Mendoza, Mónica Griselda, Nayelli Nájera, Leonardo del Valle‐Mondragón, et al.. (2019). Effect of (-)-epicatechin on the modulation of progression markers of chronic renal damage in a 5/6 nephrectomy experimental model. Heliyon. 5(4). e01512–e01512. 7 indexed citations
10.
Ramírez‐Sánchez, Israel, Aldo Moreno‐Ulloa, Francisco Villarreal, et al.. (2017). The cardioprotective effects of (-)-Epicatechin are mediated through arginase activity inhibition in a murine model of ischemia/reperfusion. European Journal of Pharmacology. 818. 335–342. 23 indexed citations
11.
Lara‐Padilla, Eleazar, et al.. (2014). The molecular fingerprint of human papillomavirus infection and its effect on the Langerhans cell population in squamous cell carcinomas of the genital skin. Indian Journal of Dermatology Venereology and Leprology. 80(4). 381–381. 1 indexed citations
12.
Gutiérrez-Salmeán, Gabriela, Ivan Rubio‐Gayosso, Eduardo Meaney, et al.. (2013). Acute effects of an oral supplement of (−)-epicatechin on postprandial fat and carbohydrate metabolism in normal and overweight subjects. Food & Function. 5(3). 521–521. 41 indexed citations
13.
Moreno‐Ulloa, Aldo, et al.. (2013). Effects of (−)-epicatechin and derivatives on nitric oxide mediated induction of mitochondrial proteins. Bioorganic & Medicinal Chemistry Letters. 23(15). 4441–4446. 42 indexed citations
14.
Rubio‐Gayosso, Ivan, Israel Ramírez‐Sánchez, Gabriela Gutiérrez-Salmeán, et al.. (2012). Testosterone metabolites mediate its effects on myocardial damage induced by ischemia/reperfusion in male Wistar rats. Steroids. 78(3). 362–369. 15 indexed citations
15.
Rubio‐Gayosso, Ivan, Israel Ramírez, Eduardo Meaney, et al.. (2008). Intraluminal-restricted 17β-estradiol exerts the same myocardial protection against ischemia/reperfusion injury in vivo as free 17β-estradiol. Steroids. 73(5). 528–538. 8 indexed citations
16.
Rubio‐Gayosso, Ivan, Steven H. Platts, & Brian R. Duling. (2006). Reactive oxygen species mediate modification of glycocalyx during ischemia-reperfusion injury. American Journal of Physiology-Heart and Circulatory Physiology. 290(6). H2247–H2256. 215 indexed citations
17.
Sierra-Ramírez, José Alfredo, T Morato, Ruy R. Campos, et al.. (2004). Acute effects of testosterone on intracellular Ca2+kinetics in rat coronary endothelial cells are exerted via aromatization to estrogens. American Journal of Physiology-Heart and Circulatory Physiology. 287(1). H63–H71. 23 indexed citations
18.
Rubio‐Gayosso, Ivan, et al.. (2002). Testosterone inhibits bradykinin-induced intracellular calcium kinetics in rat aortic endothelial cells in culture. Steroids. 67(5). 393–397. 32 indexed citations
19.
Rubio‐Gayosso, Ivan, et al.. (2000). 17??-Estradiol Increases Intracellular Calcium Concentration Through a Short-Term and Nongenomic Mechanism in Rat Vascular Endothelium in Culture. Journal of Cardiovascular Pharmacology. 36(2). 196–202. 42 indexed citations
20.
Ceballos, Guillermo, et al.. (1999). Acute and Nongenomic Effects of Testosterone on Isolated and Perfused Rat Heart. Journal of Cardiovascular Pharmacology. 33(5). 691–697. 68 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026